RETRACTED ARTICLE: A novel Internet of Things (IoT)-enabled platform for patients with type 1 diabetes

Abstract

Diabetic patients with type 1 diabetes (T1D) are constantly confronted with the decision of how much insulin to inject prior to each meal in order to maintain a healthy blood glucose level. As a result of recent research, it has been discovered that it is possible to construct an artificial pancreas (AP). The use of a closed-loop system, which combines an insulin pump with a continuous glucose monitor, can be beneficial for people with diabetes because it can help them manage their condition more effectively (CGM). The chronic disease diabetes with transient insulin resistance (T1D) necessitated daily insulin injections and close monitoring of blood glucose levels. T1D is characterised by insulin resistance that develops over time. Technologies for the management of type 1 diabetes, such as insulin pumps and Continuous Glucose Monitoring (CGM), have advanced significantly in the past decade, making them more effective in the management of type 1 diabetes patients. These systems may help to reduce treatment anxiety while also improving glycaemic control, according to the evidence. We describe how an attacker can cause physical harm to a victim by using their insulin pump, which is connected to the Internet, and how this can be done.